Disclosure 0001140361-26-032818-1

SEC FORM 4

$128,266.34

ROCKET PHARMACEUTICALS, INC. (RCKT)

Sale of 36,658 shares at $3.499 per share.

Reporting Person Stevens Christopher James · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001140361-26-032818 · filed 2026-08-13 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "ROCKET PHARMACEUTICALS, INC. (RCKT)." Disclosed 2026-08-13. https://desqlong.com/cards/0001140361-26-032818-1 (retrieved 2026-09-26).